Healthcare Services Coverage

Vitiligo Treatment Market Definition

Vitiligo treatment encompasses a range of medical strategies aimed at managing vitiligo, a condition characterized by the loss of skin color in patches. This condition results from the destruction or malfunction of melanocytes, cells responsible for producing melanin, the pigment that gives skin its color. The vitiligo treatment market consists of revenues earned by entities (organizations, sole traders and partnerships) that manufacture, distribute and sell medications and provide services designed to treat vitiligo. Treatment for vitiligo is multifaceted, catering to the needs of the condition's varying nature and its impact on individuals. It involves the use of drugs like corticosteroids and calcineurin inhibitors, which can help in restoring some color to the white patches of skin. Other drug options may also be considered, based on the patient's condition and response to initial treatments. The approach to managing vitiligo is often long-term, requiring sustained use of medication alongside other treatment modalities, to achieve and maintain skin color.

4D Printing In Healthcare Market Definition And Segments

4D printing in healthcare refers to the fabrication of customized medical devices, implants, and structures using materials that can self-transform or change shape in response to external stimuli over time. This technology builds upon 3D printing by introducing an additional dimension of functionality, enabling the printed objects to alter their shape, properties, or functionality after manufacturing. The main types of 4D printing in healthcare are fused deposition modeling (FDM), poly jet, stereolithography, and SLS. Fused deposition modeling (FDM) is a popular additive manufacturing technology used for 3D printing, its components include equipment, 3D printers, 3D bioprinters, programmable materials, shape-memory materials, hydrogels, living cells, and software and services, and it is used in hospitals and clinics, dental laboratories, and other end-users. The 4D printing in healthcare market covered in this report is segmented – 1) By Type: Fused Deposition Modeling (FDM), PolyJet, Stereolithography, Selective Laser Sintering (SLS) 2) By Component: Equipment, 3D Printers, 3D Bioprinters, Programmable Materials, Shape-Memory Materials, Hydrogels, Living Cells, Software And Services 3) By End-User: Hospitals And Clinics, Dental Laboratories, Other End-Users The 4D printing in healthcare market size has grown strongly in recent years. It will grow from $8.00 billion in 2023 to $8.65 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to patient-specific solutions demand, bioprinting and tissue engineering, innovations in 3D printing technology, and materials development. The 4D printing in healthcare market size is expected to see strong growth in the next few years. It will grow to $11.59 billion in 2028 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to personalized medicine advancements in material science, tissue engineering breakthroughs, and aging population and healthcare demands. Major trends in the forecast period include customized implants and prosthetics, responsive drug delivery systems, biocompatible and bioresorbable constructs, smart wearables for monitoring and treatment, tissue engineering and regenerative medicine.

Rising Surgical Procedures Fueling Surge in 4D Printing Adoption within the Healthcare Market

The increasing number of surgeries is expected to propel the growth of 4D printing in the healthcare market going forward. 4D printing enables the creation of customized medical implants and devices tailored to individual patient anatomy. As the number of surgeries increases, there is a growing demand for personalized medical solutions to enhance surgical outcomes and patient recovery. 4D printing allows for the fabrication of complex structures that can adapt to specific patient needs, improving treatment efficacy and patient satisfaction. For instance, in June 2022, according to the American Society for Metabolic and Bariatric Surgery (ASMBS), a US-based non-profit medical organization, in 2021, approximately 262,893 bariatric surgeries were conducted, an increase from the 198,651 bariatric surgeries performed in 2020. Furthermore, in May 2023, according to Austin Publishing Group, a US-based publishing company, the global healthcare system served more than 300 million major surgical procedures each year. Therefore, the increasing number of surgeries is driving the growth of 4D printing in the healthcare market. Major companies operating in the 4D printing in healthcare market are McKesson Corporation, Accenture plc., IBM Corporation, Oracle Corporation, Siemens Healthcare, Cognizant Technology Solutions Corporation, GE Healthcare, Quest Diagnostics, Dassault Systems, Cerner Corporation, Genpact Limited., Infor Inc., Allscripts Healthcare Solutions Inc.,, eClinicalWorks LLC, Athenahealth Inc.,, Avaya Inc.,, Stratasys Ltd, EOS GmbH Electro Optical Systems, 3D Systems Inc, The SSI Groups Inc., Materialise NV, CELLINK, CareCloud Corporation, Envisiontec Inc., Allevi Inc, Poietis SAS, Organovo Holdings Inc

Technological Integration Revolutionizing 4D Printing in Healthcare Market

Major companies operating in 4D printing in the healthcare market are focusing on new technological products, such as 4D designs, to increase their profitability in the market. 4D designs refer to three-dimensional (3D) designs that incorporate the element of time as the fourth dimension. For instance, 4D Biomaterials, a UK-based biotechnology company launched 4Degra, a photocurable polycarbonate urethane polymer. This polymer is suitable for various medical device applications, from soft and flexible to firm and rigid, and is formulated using 4D Biomaterials' unique polycarbonate-urethane chemistry. DLP, LCD, SLA, and two-photon lithography are just a few of the photocurable additive micro and macro scale processes that can be cast, applied as coatings, or 3D print 4Degra resins.

3D Systems Expands Bioprinting Capabilities with Strategic Acquisition of Volumetric Biotechnologies

In October 2021, 3D Systems, a US-based engineering company, acquired Volumetric Biotechnologies for an undisclosed amount. The acquisition is a component of 3D Systems' strategy to broaden the range of human organ production and create a vertically integrated bioprinting platform that can produce entire replacement organs. Volumetric Biotechnologies is a US-based printing technology company that operates in 4D printing in healthcare. North America was the largest region in the 4D printing in healthcare market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 4D printing in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 4D printing in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The 4D printing in the healthcare market includes revenues earned by entities by providing services such as customizable implants and prosthetics, dynamic wound dressings, and patient-specific tissue engineering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. 4D printing in the healthcare market consists of sales of drug delivery systems, smart surgical tools, biodegradable stents, responsive orthopedic devices, and adaptive wearable devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 4D printing in healthcare market research report is one of a series of new reports from The Business Research Company that provides 4D printing in healthcare market statistics, including 4D printing in healthcare industry global market size, regional shares, competitors with 4D printing in healthcare market share, detailed 4D printing in healthcare market segments, market trends, and opportunities, and any further data you may need to thrive in the 4D printing in healthcare industry. This 4D printing in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cell Lysis And Fractionation Market Definition And Segments

Cell lysis is the process of breaking open a cell, which allows the release of its contents, while cell fractionation is a multi-step laboratory procedure used to divide a cell's organelles into various layers or fractions or sections. The main types of cell lysis and fractionation are mammalian cells and microbial cells. Mammalian cells are eukaryotic cells that are derived from mammals and are used in cell culture and biomanufacturing of therapeutic proteins and viral vaccines. These are used for various applications, such as nucleic acid purification and isolation and protein purification and isolation, and are used by several end users, including research laboratories and institutes, biopharmaceutical, and biotechnology companies. The cell lysis and fractionation market covered in this report is segmented – 1) By Type: Mammalian Cells, Microbial Cells 2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation 3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies The custom shoes market size has grown strongly in recent years. It will grow from $3.14 billion in 2023 to $3.42 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing investments in life science research, growing focus on personalized medicine, high prevalence of diseases, technological advancements in cell lysis and fractionation methods, rising demand for biopharmaceuticals and biotechnology products. The custom shoes market size is expected to see strong growth in the next few years. It will grow to $4.57 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing focus on personalized medicine, increasing government funding for research, high demand for effective cell lysis and fractionation methods, technological advancements in the field of genomics and proteomics, rising prevalence of chronic and infectious diseases. Major trends in the forecast period include continued growth in the adoption of personalized medicine approaches, increasing integration of automation and robotics in lysis and fractionation processes, expansion of applications in clinical diagnostics and drug development, advancements in microfluidics and lab-on-a-chip technologies for cell analysis, growing emphasis on point-of-care and decentralized testing solutions.

Growing Emphasis On Personalized Medicine Fuels Cell Lysis And Fractionation Market Expansion

A growing focus on personalized medicine is expected to propel the growth of the cell lysis and fractionation markets going forward. Personalized medicine is an emerging practice of medicine that uses an individual's genetic profile for the diagnosis and treatment of disease. It involves tailoring medical decisions and treatments to the individual characteristics of each patient, particularly focusing on their genetic makeup. Cell lysis and fractionation play a crucial part in precision medicine by making it possible to separate and analyze particular subcellular elements from patient samples, including proteins, organelles, and nucleic acids. This makes it possible for scientists and medical professionals to investigate the molecular processes that underlie illness and create customized treatments depending on the unique molecular traits of each patient. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines will be on the market for people with multiple types of cancer, genetic rare diseases, and a range of chronic and infectious diseases. Therefore, the growing focus on personalized medicine is driving the growth of the cell lysis and fractionation markets. Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Increasing Focus On Introducing Viral Vector Lysis Kit For Enhanced Cell Lysis And Fractionation Solutions

Major companies operating in the cell lysis and fractionation market are focused on introducing advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain a competitive edge in the market. These lysis kits offer a simplified AAV (Adeno-associated virus) lysis methodology that will improve SOPs (Standard Operating Procedures), quality control, and safety while standardizing bioprocessing workflows. For instance, in July 2023, QIAGEN, a Germany-based provider of sample and assay technologies, launched the new CGT Viral Vector Lysis Kit, which makes it possible to quantify virus titers for several serotypes with an exact and uniform procedure starting with cell lysates. The new CGT viral vector lysis kit complements QIAGEN's rapidly expanding digital PCR portfolio for the biopharma industry, which already includes three QIAcuity Residual DNA Quantification Kits to check for host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for use in adeno-associated virus (AAV) titer quantification.

MilliporeSigma Expands Bioreactor And Cell Culture Portfolio With Acquisition Of Erbi Biosystems Inc.

In December 2022, MilliporeSigma, a US-based pharmaceutical company, acquired Erbi Biosystems Inc. for an undisclosed amount. With this acquisition, MilliporeSigma aims to strengthen its portfolio and expertise in the field of bioreactors and cell culture technologies. Erbi Biosystems is the developer of the 2 ml micro-bioreactor platform technology known as Breez, which is a micro-scale, fully automated, functionally closed system. Erbi Biosystems Inc. is a US-based biotechnology company that offers microfluidic solutions to enable efficient and controlled cell lysis and fractionation. North America was the largest region in the cell lysis and fractionation market in 2023. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cell lysis and fractionation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The cell lysis and fractionation market consists of revenues earned by entities by providing cellular contents extraction, cytoplasmic separation, and cell disruption. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell lysis and fractionation market also includes sales of cell lysis instruments, cell lysis reagents, and consumables. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The cell lysis and fractionation market research report is one of a series of new reports from The Business Research Company that provides cell lysis and fractionation market statistics, including cell lysis and fractionation industry global market size, regional shares, competitors with cell lysis and fractionation market share, detailed cell lysis and fractionation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell lysis and fractionation industry. This cell lysis and fractionation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Corporate Wellness Solutions Market Definition And Segments

Corporate wellness solutions refer to programs, services, and initiatives implemented by organizations to promote the health and well-being of their employees. These solutions are designed to improve employees' physical, mental, and emotional health, leading to higher productivity, lower healthcare costs, and improved employee morale. The main services of corporate wellness solutions are health risk assessment, fitness, smoking cessation, health screening, nutrition and weight management, stress management, and others. Corporate wellness solutions include health risk assessments (HRAs) that help employees understand their current health status, identify potential health risks, and receive personalized recommendations for improving their health. The cloud-based and on-premises products are delivered as onsite and offsite models for large organization, medium-sized organization, and small organization end users. The corporate wellness solutions market covered in this report is segmented – 1) By Service: Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition And Weight Management, Stress Management, Other Services 2) By Product: Cloud-Based, On-Premises 3) By Delivery Model: Onsite, Offsite 4) By End-User: Large Organization, Medium-sized Organization, Small Organizations The corporate wellness solutions market size has grown strongly in recent years. It will grow from $77.14 billion in 2023 to $84.76 billion in 2024 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to rising adoption of corporate wellness programs, rising adoptions of corporate wellness programs to promote wellbeing of employees, longer working hours and a longer life expectancy, rising adoption of corporate wellness programs by employers, and rising healthcare costs. The corporate wellness solutions market size is expected to see strong growth in the next few years. It will grow to $121.02 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. the growth in the forecast period can be attributed to rising prevalence pf obesity and lifestyle related disorders, growing awareness about stress and prevalence of chronic diseases, increased uptake of technology-powered corporate wellness solutions, employee productivity and performance, and chronic disease prevention. Major trends in the forecast period include emerging countries with a large working population, the focus on workforce health is becoming more prominent globally, use of technology to engage employees in wellness programs, digital wellness platforms, remote work wellness.

Stress Management Revolution Fueling Growth In The Corporate Wellness Solutions Market

A rising focus on stress management is expected to propel the growth of the corporate wellness solutions market going forward. Stress management refers to the process of acquiring and practicing a variety of cognitive and behavioral techniques to manage and cope with stress. Corporate wellness solutions improve productivity, job satisfaction, and overall well-being by creating a workplace environment that supports employees' mental health and helps them effectively manage stress. For instance, according to the 2022 Mind the Workplace report published by Mental Health America, a US-based non-profit organization, in 2021, an analysis of survey responses from over 11,300 U.S. employees across 17 industries revealed that 71% of the respondents found it challenging to concentrate at work, compared to 65% in 2020. Therefore, the rising focus on stress management is driving the growth of the corporate wellness solutions market. Major companies operating in the corporate wellness solutions market are UnitedHealth Group, CVS Health Corporation, Elevance Health, Inc, Centene Corporation, Well Nation, Telus Corporation, Cleveland Clinic, Cerner Corporation, Provant Health Solutions Inc., Privia Health Gr, Fitbit, Inc., Beacon Health Options, Wellness Corporate Solutions, LLC, ComPsych Corporation, Virgin Pulse, Vitality Group, EXOS, Medcan Clinic, Aduro Biotech Inc., Wellsource, Inc., Truworth Wellness, Central Corporate Wellness, Marino Wellness, SOL Wellness

Albertsons Companies Launches Sincerely Health, A Groundbreaking Digital Health And Wellness Platform

Major companies operating in the corporate wellness solutions market are developing digital wellness platforms to enhance employee well-being by providing a range of features and tools. A digital wellness platform is a technology-based solution designed to promote and support various aspects of well-being, including physical, mental, and emotional health, through digital tools and resources. For instance, in February 2023, Albertsons Companies Inc., a US-based food and drug retailer, launched Sincerely Health, a digital health and wellness platform that offers personalized health and pharmacy services, enabling customers to achieve their health and wellness goals with reward points redeemable for groceries. Sincerely health is designed to empower users to make informed choices about food, physical activity, sleep, and mindfulness to improve their overall well-being. The platform also provides nutrition insights and lets customers make informed choices about the Health.

TELUS Corporation Strengthens Global Leadership In Digital Health With Lifeworks Inc. Acquisition

In September 2022, TELUS Health, a Canada-based digital health technology provider, acquired LifeWorks Inc. for $2.3 billion. The acquisition enhances TELUS's position in the corporate wellness solutions market by combining TELUS Health's existing suite of advanced digital health technologies with LifeWorks' world-leading digital and in-person solutions that support the total well-being of physical, financial, and social aspects. Further, the acquisition significantly accelerates TELUS Health's vision of employer-based healthcare, increasing employee access to high-quality, proactive healthcare and mental wellness by unifying digital-first solutions across the health and wellness spectrum. LifeWorks Inc. is a Canada-based provider of a range of corporate wellness solutions to promote employees' mental, physical, social, and financial well-being. North America was the largest region in the corporate wellness solutions market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the corporate wellness solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the corporate wellness solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The corporate wellness solutions market includes revenues earned by entities by providing services such as wellness coaching, fitness and exercise programs, mental health support, biometric screening, substance abuse management, and employee assistance programs. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The corporate wellness solutions market research report is one of a series of new reports from The Business Research Company that provides corporate wellness solutions market statistics, including corporate wellness solutions industry global market size, regional shares, competitors with a corporate wellness solutions market share, detailed corporate wellness solutions market segments, market trends and opportunities, and any further data you may need to thrive in the corporate wellness solutions industry. This corporate wellness solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital Genome Market Definition And Segments

The digital genome refers to the digitized and organized collection of an organism's genetic material, including its DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) sequences. This digital representation allows for storing, analyzing, and interpreting genetic information using computational tools and technologies. Digital genomes are essential for understanding genetic variations, disease mechanisms, and evolutionary relationships. The main types of digital genome are sequencing and analyzer instruments, and data analysis and management tools. Sequencing and analyzer instruments refer to equipment used in genomic sequencing and analysis processes, which are essential for decoding the genetic information contained within DNA and RNA molecules. They are used for various applications such as diagnostics, agriculture and animal research, personalized medicine, drug discovery, and treatment analysis by research centers and government institutes, academic institutions, pharmaceutical and biotechnology industries, hospitals, and diagnostic centers. The digital genome market covered in this report is segmented – 1) By Type: Sequencing And Analyzer Instruments, Data Analysis And Management Tools 2) By Application: Diagnostics, Agriculture And Animal Research, Personalized Medicine, Drug Discovery, Treatment Analysis 3) By End User: Research Centers And Government Institutes, Academic Institutions, Pharmaceutical And Biotechnology Industries, Hospitals, Diagnostic Centers The digital genome market size has grown rapidly in recent years. It will grow from $32.25 billion in 2023 to $39.25 billion in 2024 at a compound annual growth rate (CAGR) of 19.7%. The growth in the historic period can be attributed to growing funding for genomics, reduced cost and high speed of DNA sequencing, entry of new players and start-ups in developing economies, increasing number of drug discoveries, and growing biotech sector. The digital genome market size is expected to see rapid growth in the next few years. It will grow to $80.93 billion in 2028 at a compound annual growth rate (CAGR) of 19.8%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, increasing research and development pertaining to digital genome, growing adoption of personalized medicine, developments in biotechnology, and rising prevalence of chronic diseases. Major trends in the forecast period include the increasing adoption of next-generation sequencing technologies, increasing technological advancements, extensive use of microorganisms in diagnostics industry, increasing demand for personalized medicines, and rising adoption of digital genomic technology by hospitals and clinics.

Impact Of Increasing Prevalence Of Genetic Disorders On The Digital Genome Market

The increasing prevalence of genetic disorders is expected to propel the growth of the digital genome market going forward. Genetic disorders are hereditary conditions caused by abnormalities or mutations in an individual's DNA, the genetic material that carries instructions for the development and functioning of the body. Digital genome technologies enable the identification of genetic mutations and variations associated with genetic disorders. This information helps in accurate and early diagnosis of these disorders, allowing for timely intervention and treatment. For instance, in August 2023, according to the National Library of Medicine, a US-based medical library, sickle cell anemia is a genetic disease that affects approximately 1 in 500 African Americans in the United States. Further, about 1 in 12 African Americans carries the autosomal recessive mutation responsible for the disease, and approximately 300,000 infants are born with sickle cell anemia annually. Therefore, the increasing prevalence of genetic disorders is driving the growth of the digital genome market. Major companies operating in the digital genome market are Roche Holding AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Quest Diagnostics, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., BGI Genomics, Myriad Genetics Inc., Foundation Medicine Inc., ArcherDx Inc., Invitae Corporation, Oxford Nanopore Technologies Ltd., Luminex Corporation, GenMark Diagnostics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Genewiz, Inscripta Inc., Genomic Health Inc., Becton Dickinson and Company, GenomeMe, Regeneron Pharmaceuticals Inc.

Innovative Products In The Digital Genome Market Illumina's NovaSeq X Series Advancement

Major companies operating in the digital genome market are developing innovative products such as the NovaSeq X Series to understand disease and ultimately transform patient lives. NovaSeq X Series includes the NovaSeq X and NovaSeq X Plus systems, with the NovaSeq X Plus capable of sequencing more than 128 genomes per run and generating more than 20,000 whole genomes per year. For instance, in September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series, a significant advancement in whole-genome sequencing technology. The system incorporates cost-efficiency throughout the workflow, streamlined informatics, operational simplicity, sustainability advancements, and world-class support. It also enables broader and deeper sequencing, allowing users to scale up any application to include more samples and analyze data more efficiently. The NovaSeq X Series is designed to be the most potent and cost-effective sequencing system, with improved reagent stability and faster data transfers due to optimized genomics data compression. The system was purpose-built for improved sustainability, with a smaller data footprint that reduces storage and energy consumption costs.

Genome Medical Acquires GeneMatters Strengthening Leadership In Virtual Genetics Counseling And Genomic Services

In August 2021, Genome Medical, a US-based genomic care delivery company, acquired GeneMatters for $60 million. This acquisition aimed to strengthen Genome Medical's position in the virtual genetics counseling space and expand its capabilities in providing genetic services to a broader patient and provider base. Further, the acquisition brought together two prominent teams of industry innovators and clinical experts, positioning Genome Medical as a clear digital health leader for genomic medicine. GeneMatters is a US-based telehealth genetic counseling and software solutions company that offers digital genome services. North America was the largest region in the digital genome market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital genome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital genome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The digital genome market consists of revenues earned by entities by providing services such as DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) isolation, profiling, qPCR, next-generation sequencing, and advanced bioinformatics data analysis pipelines. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital genome market also includes sales of sequencing and analyzer instruments, sequencing chips, sample preparation instruments, and sequencing and analysis software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The digital genome market research report is one of a series of new reports from The Business Research Company that provides digital genome market statistics, including digital genome industry global market size, regional shares, competitors with a digital genome market share, detailed digital genome market segments, market trends and opportunities, and any further data you may need to thrive in the digital genome industry. This digital genome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Digital Twins In Healthcare Market Definition And Segments

A digital twin in healthcare refers to a virtual replica of physical entities such as patients and hospital environments in virtual form, incorporating real-time data from sources such as electronic health records and physiological measurements. These digital replicas facilitate personalized treatment plans, predictive analytics, and enhanced clinical operations by integrating real-time data and virtual simulations. The main types of digital twins in healthcare are process and system digital twins, and product digital twins. A Process and System Digital Twin refers to a virtual representation of a physical process or systems applications including asset and process management, personalized medicine, and drug discovery, and it is used in clinical research organizations, research and diagnostic laboratories, hospitals, and clinics. The digital twins in healthcare market covered in this report is segmented – 1) By Type: Process And System Digital Twin, Product Digital Twin 2) By Application: Asset And Process Management, Personalized Medicine, Drug Discovery, 3) By End-User: Clinical Research Organizations (CROs), Research And Diagnostic Laboratories, Hospitals And Clinics The digital twins in healthcare market size has grown exponentially in recent years. It will grow from $1.31 billion in 2023 to $1.96 billion in 2024 at a compound annual growth rate (CAGR) of 49.5%. The growth in the historic period can be attributed to Increasing adoption of digital twin technology in manufacturing and aerospace industries, Advancements in IoT and cloud computing technologies, Growing demand for predictive maintenance and real-time analytics, Growing demand for predictive maintenance and real-time analytics, and Increasing investments in digital twin technology by public and private entities. The digital twins in healthcare market size is expected to see exponential growth in the next few years. It will grow to $9.69 billion in 2028 at a compound annual growth rate (CAGR) of 49.2%. The growth in the forecast period can be attributed to Increasing adoption of digital twin technology in the healthcare industry, Growing demand for real-time data analytics, Advancements in machine learning and artificial intelligence, Increasing focus on patient-centered care, and Growing demand for predictive analytics and preventive interventions. Major trends in the forecast period include Increasing use of digital twins for drug discovery and development, Growing demand for patient remote monitoring, Increasing use of digital twins for customized medicine, Growing use of digital twins for surgery planning, and Increasing use of digital twins for epidemic management,

Harnessing Simulation Technology For Remote Patient Monitoring And Personalized Care

The expansion of telehealth is expected to propel the growth of digital twins in the healthcare market going forward. Telehealth refers to using telecommunications technology to provide healthcare services and information remotely. It encompasses various healthcare services, including medical consultations, monitoring, education, and health information exchange, all delivered through digital communication channels. Digital twins can simulate real-time physiological responses and disease progression for individual patients. Telehealth platforms can use this information for remote monitoring, enabling healthcare providers to remotely track patients' vital signs, medication adherence, and overall health. For instance, in February 2023, according to Rock Health Inc., a US-based health technology company, four out of five consumers had utilized a telemedicine service at least once. Additionally, telemedicine use increased significantly in 2022 among underrepresented groups in healthcare. Telemedicine adoption increased by 12% among people over the age of 55, and rural residents adopted telemedicine at a 13% higher rate. Therefore, telehealth expansion is driving the growth of digital twins in the healthcare market. Major companies operating in the digital twins in healthcare market are Amazon.com Inc., Microsoft Corporation, IBM Corporation, Oracle Corporation, SAP SE, NVIDIA Corporation, Siemens AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., NTT DATA Corporation, Atos SE, Dassault Systemes SE, Ansys Inc., PTC Inc., Twin Health Inc., Faststream Technologies, Rescale Inc., ThoughWire Corp., Q Bio Inc., Verto Healthcare, Unlearn.AI Inc., PrediSurge, QiO Technologies Ltd., NUREA, Predictive Care Inc., Virtonomy GMbH

Revolutionary Digital Twin Avatar Redefining Healthcare Awareness And Personalized Medicine

Major companies operating in digital twins in the healthcare market are developing innovative digital twin-supported technology, such as Emma, to raise awareness of the role of virtual twins in accelerating medical research and delivering personalized care. Emma is a digital twin-supported technology that provides an interactive, true-to-life virtual replica with additional data points, insights, and analysis that enhance the experience. The technology can optimize surgical procedures and give patients a greater understanding of treatment options. For instance, in September 2023, Dassault Systèmesa SE, a France-based software company, launched a digital twin avatar named Emma to raise awareness about health research. Emma is a virtual model that accurately reflects the characteristics of a physical being. Emma was developed using anonymous health data to conduct numerous tests to gain insight into various diseases and therapies.

Siemens AG Strengthens Portfolio With Acquisition Of EcoDomus Inc.

In December 2021, Siemens AG, a Germany-based automation company, acquired EcoDomus Inc. for an undisclosed amount. With this acquisition, Siemens AG aims to integrate EcoDomus' technology into its portfolio to enhance or diversify its offerings. EcoDomus Inc. is a US-based company that provides digital twin software solutions. North America was the largest region in the digital twins in healthcare market in 2023. The regions covered in the digital twins in healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digital twins in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The digital twins in healthcare market includes revenues earned by entities by replicating staffing systems, creating digital twins of healthcare facilities, interdisciplinary teamwork and patient care coordination, training and simulation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The digital twins in healthcare market research report is one of a series of new reports from The Business Research Company that provides digital twins in healthcare market statistics, including digital twins in healthcare industry global market size, regional shares, competitors with digital twins in healthcare market share, detailed digital twins in healthcare market segments, market trends, and opportunities, and any further data you may need to thrive in the digital twins in healthcare industry. This digital twins in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Electronic Trial Master File (eTMF) Systems Market Definition And Segments

An electronic trial master file (eTMF) is a trial master file in electronic or digital format, serving as a content management system for the pharmaceutical industry. The eTMF system manages, stores, tracks, and archives essential clinical study documents electronically. It is designed to ensure compliance with regulatory requirements, such as the FDA's Title 21 CFR Part 11, and to provide a secure, centralized, and easily accessible repository for clinical trial documents. The main components of electronic trial master file (eTMF) systems are services and services. The electronic trial master file (eTMF) system services refer to functionalities or features provided by the eTMF system to support the management of clinical trial documentation in electronic format. It is delivered on-premise and cloud-based and used in pharmaceutical and biotechnology companies, contract research organizations, and other users. The electronic trial master file (eTMF) systems market covered in this report is segmented – 1) By Component: Services, Software 2) By Delivery Mode: On-Premise, Cloud-Based 3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs), Other End-Users The electronic trial master file (eTMF) market size has grown rapidly in recent years. It will grow from $1.19 billion in 2023 to $1.36 billion in 2024 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to increasing regulatory compliance requirements, rise in clinical trial complexity, globalization of clinical trials, paper-based document challenges, and increasing emphasis on data quality and integrity. The electronic trial master file (eTMF) market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2028 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to integration with electronic health records (eTMF), rapid growth in clinical trials, focus on patient-centric trials, and emphasis on real-time monitoring and reporting. Major trends in the forecast period include growing demand for AI-powered eTMF systems, increasing focus on data analytics and insights, growing importance of patient-centric trials, and adoption of cloud-based eTMF solutions.

Driving The Surge In Electronic Trial Master File (eTMF) Systems Market Growth

The increase in the number of clinical trials is expected to propel the growth of the electronic trial master file (eTMF) systems market going forward. Clinical trials are systematic investigations or studies conducted to assess the safety, efficacy, and effectiveness of human medical interventions, treatments, or procedures. These trials aim to generate reliable data and evidence to determine whether a new drug, therapy, medical device, or intervention is safe and effective for use in a specific patient population. The upsurge in clinical trials is intricately linked to the widespread adoption of electronic trial master file (eTMF) systems. As the volume and complexity of clinical research expand, eTMF systems play a pivotal role in streamlining documentation processes, ensuring regulatory compliance, and facilitating efficient collaboration among stakeholders. For instance, in November 2023, according to a report published by the Association of the British Pharmaceutical Industry, a UK-based trade association, the total number of clinical trials increased to 411 trials in 2022 and 394 trials in 2021. The annual recruitment to industry clinical trials in the UK is up by 5,366 participants yearly to 42,088 in 2022–23. Therefore, the increase in clinical trials is expected to propel the growth of the electronic trial master file (eTMF) systems market. Major companies operating in the electronic trial master file (eTMF) systems market are Veeva Systems, Oracle, TransPerfect, Phlexglobal, SureClinical Inc. , Aurea, Inc., MasterControl, Inc, Clinevo Technologies , Covance Inc.,, Ennov, Care Lex, ePharma Solutions, Database Integrations, Inc, Aris Global LLC, Mayo Foundation for Medical Education and Research, Montrium Inc., StrelingBio Inc., PHARMAVIGILANT, Forte research, IQVIA, Labcorp Drug Development, NCGD Inc, arivis AG , Wingspan Technology, Dell EMC, Paragon Solutions, Freyr, SAFE-BioPharma, BIOVIA Corp

Enhancing Clinical Trial Efficiency With Expert-Led Trial Master File Services

Major companies operating in the electronic trial master file (eTMF) systems market are focused on developing innovative products such as cloud-based eTMF to meet the growing demand. Cloud-based eTMF (electronic trial master file) refers to a digital platform or system hosted on cloud infrastructure and specifically designed to manage and organize essential documents and data related to clinical trials in the life sciences and pharmaceutical industries. For instance, in September 2022, Montrium Inc., a Canada-based cloud-based software solutions company, launched cloud-based trial master file (TMF) services and TMF maturity educational training. These offerings are designed to support clinical operations and TMF teams at every stage of the clinical development journey. The comprehensive service offerings are backed by years of experience in TMF processes and cutting-edge technology, leveling the playing field for scaling organizations by allowing them to achieve the highest standard of TMF excellence.

Veeva Systems Acquires Veracity Logic To Enhance Clinical Trial Efficiency

In December 2021, Veeva Systems Inc., a US-based cloud computing company, acquired Veracity Logic for an undisclosed amount. The acquisition will help Veeva simplify complex processes and expedite clinical trials, indicating its relevance to the eTMF systems market. Veracity Logic LLC is a US-based company that delivers eTMF (electronic trial master file) and eClinical solutions. North America was the largest region in the electronic trial master file (eTMF) systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electronic trial master file (eTMF) systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the electronic trial master file (eTMF) systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The electronic trial master file (eTMF) Systems market includes revenues earned by entities through implementation and integration services, document migration services, quality control and compliance services and regulatory submission support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The electronic trial master file (eTMF) Systems market consists of sales of cloud-based eTMF solutions, eTMF software solutions, mobile applications, collaboration and communication tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The electronic trial master file systems market research report is one of a series of new reports from The Business Research Company that provides electronic trial master file systems market statistics, including electronic trial master file systems industry global market size, regional shares, competitors with electronic trial master file systems market share, detailed electronic trial master file systems market segments, market trends, and opportunities, and any further data you may need to thrive in the electronic trial master file systems industry. This electronic trial master file systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Healthcare Assistive Robot Market Definition And Segments

Healthcare assistive robots are intelligent machines designed to help individuals with disabilities, the elderly, or those requiring care by performing mobility support, patient monitoring, and rehabilitation exercises. They enhance healthcare delivery by assisting with physical tasks, providing companionship, and enabling remote health monitoring and communication. These robots improve quality of life, foster greater independence, and reduce the workload on healthcare professionals. The main types of healthcare assistive robots are care robots and surgical assistive robots. Care robots are designed to assist in the care of patients, providing support with daily activities, emotional interaction, or monitoring health conditions. The types of portability include fixed base and mobile. These are used by various end users, such as hospitals, clinics, ambulatory surgical centers, and others. The healthcare assistive robot market covered in this report is segmented – 1) By Type: Care Robot, Surgical Assistive Robot 2) By Portability: Fixed Base, Mobile 3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users The healthcare assistive robot market size has grown exponentially in recent years. It will grow from $1.09 billion in 2023 to $1.32 billion in 2024 at a compound annual growth rate (CAGR) of 20.7%. The growth in the historic period can be attributed to aging population, increasing chronic disease prevalence, regulatory support and funding, increasing disposable income, rise in sports-related injuries, growth in medical tourism in developing economies. The healthcare assistive robot market size is expected to see exponential growth in the next few years. It will grow to $2.75 billion in 2028 at a compound annual growth rate (CAGR) of 20.2%. The growth in the forecast period can be attributed to labor shortages in healthcare, rising healthcare costs, increased focus on patient care, growing awareness of assistive needs, expansion of telemedicine. Major trends in the forecast period include technological advancements, advancements in mobility solutions, integration of ai and machine learning, advances in human-robot interaction, innovation in wearable technologies.

Navigating The Surge In Orthopedic Disorders With Robotics In Healthcare

The increasing incidence of orthopedic disorders is expected to propel the growth of the healthcare assistive robot market going forward. Orthopedic disorders refer to a broad category of conditions that affect the musculoskeletal system, which includes bones, joints, ligaments, tendons, muscles, and nerves. Healthcare assistive robots for orthopedic disorders help support mobility and rehabilitation and perform precise surgical procedures, thereby enhancing patient care and recovery. For instance, in August 2023, according to the Institute for Health Metrics and Evaluation (IHME), a US-based research institution, nearly 1 billion people will experience osteoarthritis, with knee cases increasing by 75% and hand cases by 50% by 2050. Therefore, the increasing incidence of orthopedic disorders is driving the growth of the healthcare assistive robot market. Major companies operating in the healthcare assistive robot market are HONDA Motor Co. Ltd., Johnson & Johnson, Medtronic PLC, ABB Ltd., Stryker Corporation, TE Connectivity Ltd., Zimmer Biomet Holdings Inc., Fanuc Corporation, Intuitive Surgical Inc., KUKA AG, OmniCell Inc., Globus Medical Inc., SoftBank Robotics Group Corp., Kinova Inc., CMR Surgical Ltd., Diligent Robotics Inc., Cyberdyne Inc., Ekso Bionics Holdings Inc., AlterG Inc., Titan Medical Inc., ReWalk Robotics Ltd., Focal Meditech BV, Barrett Technology, Rex Bionics Ltd., Bionik Laboratories Corp.

Introduction To Technological Advancements Of Rehab Robotics In The Healthcare Assistive Robots Market

Major companies operating in the healthcare assistive robot market are developing innovative technologies, such as gait therapy software, to increase their profitability in the market. Gait therapy software refers to specialized programs that guide robots in assisting patients with walking exercises, aiming to improve mobility and rehabilitation outcomes. For instance, in January 2024, Ekso Bionics Holdings Inc., a US-based robotic exoskeleton manufacturer, launched GaitCoach Software for EksoNR, a clinical rehabilitation wearable robot designed for exoskeletal assistance. This revolutionized gait therapy with its capability to tailor sessions to individual patient needs, provide real-time, dynamic feedback, and deliver precise guidance akin to that of an additional clinical observer. This innovative software, which succeeds SmartAssist, enhances the integration of robotics in rehabilitation, as evidenced by 96% of experienced EksoNR users finding it highly intuitive and 93% valuing its guidance for simplifying usage.

Indego Joins Ekso Bionics In Strategic Acquisition From Parker Hannifin

In December 2022, Ekso Bionics Holdings Inc., a US-based robotic exoskeleton manufacturer, acquired a human motion and control business unit, including the indigo product line, from Parker Hannifin Corporation for an undisclosed amount. Through this acquisition, Ekso Bionics aims to expand its exoskeleton offerings into home use, collaborate with Vanderbilt University as a significant partner, and unite premier lower extremity robotics firms, enriching its medical solutions with superior technology and expertise. Parker Hannifin Corporation is a US-based manufacturer of motion and control technologies and systems, including healthcare robotics. North America was the largest region in the healthcare assistive robot market in 2023. The regions covered in the healthcare assistive robot market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the healthcare assistive robot market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The healthcare assistive robot market consists of revenues earned by entities by providing services such as patient care and monitoring, assistance with daily activities, surgical assistance, telepresence and remote care, disinfection and sanitation, physical therapy, and rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The healthcare assistive robot market also includes sales of mobility assistance robots, patient transfer robots, prosthetic and orthotic robots, telepresence robots, surgical robots, rehabilitation robots, social assistance robots, disinfection robots, medication dispensing robots, and diagnostic robots. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The healthcare assistive robot market research report is one of a series of new reports from The Business Research Company that provides healthcare assistive robot market statistics, including healthcare assistive robot industry global market size, regional shares, competitors with a healthcare assistive robot market share, detailed healthcare assistive robot market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare assistive robot industry. This healthcare assistive robot market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.